Mangalam Drugs

Mangalam Drugs and Organics Ltd Half Yearly Results

NSEBSE

₹105.31

(-1.37%)

Jan 21, 2025|03:31:25 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Sept-2024	Mar-2024	Sept-2023
Gross Sales	156.25	198.98	168.37
Excise Duty	0	0	0
Net Sales	156.25	198.98	168.37
Other Operating Income	0.23	0.59	0.65
Other Income	0.16	0.03	0.07
Total Income	156.64	199.6	169.09
Total Expenditure	139.58	180.88	170.32
PBIDT	17.05	18.72	-1.23
Interest	7.41	7.26	6.66
PBDT	9.64	11.46	-7.89
Depreciation	7.85	7.49	7.16
Minority Interest Before NP	0	0	0
Tax	0.01	0.09	0.11
Deferred Tax	-3.6	-0.15	-2.05
Reported Profit After Tax	5.37	4.03	-13.1
Minority Interest After NP	0	0	0
Net Profit after Minority Interest	5.37	4.03	-13.1
Extra-ordinary Items	0	0	0
Adjusted Profit After Extra-ordinary item	5.37	4.03	-13.1
EPS (Unit Curr.)	3.4	2.54	-8.28
Book Value (Unit Curr.)	0	0	0
Dividend (%)	0	0	0
Equity	15.83	15.83	15.83
Public Shareholding (Number)	0	0	0
Public Shareholding (%)	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0
Non Encumbered - No. of Shares	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0
Non Encumbered - % in Total Equity	0	0	0
PBIDTM(%)	10.91	9.4	-0.73
PBDTM(%)	-	-	-
PATM(%)	3.43	2.02	-7.78

No Record Found

Invest wise with Expert advice